Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jun 2:2:9.
doi: 10.1186/s40733-016-0024-8. eCollection 2016.

Potential of molecular based diagnostics and its impact on allergen immunotherapy

Giovanni Melioli  1 , Eleonora Savi  2 , Maria Angiola Crivellaro  3 , Giovanni Passalacqua  4
Affiliations

Potential of molecular based diagnostics and its impact on allergen immunotherapy

Giovanni Melioli et al. Asthma Res Pract. .

Abstract

Molecular based in vitro technologies greatly changed the diagnostic approaches in allergy. At present, sensitization profiles can be dissected according to IgE subsets, which are specific for genuine or cross-reacting components and potentially dangerous or virtually harmless components. The identification of IgE in components with specific characteristics has a direct impact on the accuracy of the diagnosis (indeed, it is possible at present to not only identify the allergen derived from a given allergen source but also the family of molecules to which the patient is sensitized), on the prognosis of the patient's allergy, and on the prevention activities to be implemented. More interestingly, during the last few years, and thanks to the tools of molecular diagnostics, the indications for Allergen Immunotherapy (AIT) have also be modified, and novel strategies for the selection of the allergens to be administered have been better defined. Indeed, protocols indicating how Molecular Based Diagnosis (MBD) can be used to identify the best AIT approach have been recently published. In this review, the rationale for the use of MBD tools is discussed, and the recent strategies for the choice of allergens to be used in AIT are reported.

Keywords: Allergen Immunotherapy; Components; In vitro diagnosis; Molecular based diagnosis.

PubMed Disclaimer

References

    1. Heiss S, Mahler V, Steiner R, Spitzauer S, Schweiger C, Kraft D, et al. Component-resolved diagnosis (CRD) of type I allergy with recombinant grass and tree pollen allergens by skin testing. J Invest Dermatol. 1999;113(5):830–7. doi: 10.1046/j.1523-1747.1999.00796.x. - DOI - PubMed
    1. Canonica GW, Ansotegui IJ, Pawankar R, Schmid-Grendelmeier P, van Hage M, Baena-Cagnani CE, et al. A WAO - ARIA - GA(2)LEN consensus document on molecular-based allergy diagnostics. World Allergy Organ J. 2013;6(1):17. doi: 10.1186/1939-4551-6-17. - DOI - PMC - PubMed
    1. Van Gasse AL, Mangodt EA, Faber M, Sabato V, Bridts CH, Ebo DG. Molecular allergy diagnosis: status anno 2015. Clin Chim Acta. 2015;444:54–61. doi: 10.1016/j.cca.2015.02.012. - DOI - PubMed
    1. Melioli G, Canonica GW. Molecular allergy diagnosis: we need to become more knowledgeable. Ann Allergy Asthma Immunol. 2012;108(6):387. doi: 10.1016/j.anai.2012.04.011. - DOI - PubMed
    1. Caminati M, Savi E, Villalta D, Passalacqua G, Triggiani M, Senna G. Component resolved diagnosis (CRD): how much is it presently used by Italian allergists? Eur Ann Allergy Clin Immunol. 2014;46(3):106–8. - PubMed

LinkOut - more resources